Suneel Gupta Net Worth & Insider Trades
Suneel Gupta - Chief Development Officer, Protagonist Therapeutics, Inc
What is Suneel Gupta's Net Worth?
The current estimated net worth of Protagonist Therapeutics, Inc's Chief Development Officer, Suneel Gupta, is estimated to be about $8.59M . Suneel Gupta owns about 49,500 units of Protagonist Therapeutics, Inc common stock. In the last 4 years at Protagonist Therapeutics, Inc, Suneel Gupta has sold an estimated value of $123.95K worth.
What is Suneel Gupta's Past Insider Trading?
Suneel Gupta's largest purchase order was 30,000 units , worth over $153.9K on December 3, 2019. In total, Suneel Gupta has made about 11 transactions over 4 years of their time at Protagonist Therapeutics, Inc. Suneel Gupta usually trades in February, with the busiest year in 2022, 2023 and 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Suneel Gupta
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Suneel Gupta's Salary in 2020?
As Chief Development Officer of Protagonist Therapeutics, Inc, Suneel Gupta has a total base salary of $420,000 . Suneel Gupta received compensation valued at about $1,108,270 in 2020 after becoming Chief Development Officer. The vast majority of their compensation came in the form of option awards of $427,950 , other earnings, plans or compensations of $256,200 , and other compensation of $4,120 .
What is Suneel Gupta's' Mailing Address?
- Mailing address is 7707 Gateway Blvd., Suite 140 Newark CA 94560 CA
Protagonist Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Dinesh V. Patel, Ph.D. | 2020 | $565,000 | - | $1,183,155 | $473,894 | $3,573 | $2,225,622 |
| Dinesh V. Patel, Ph.D. | 2019 | $545,000 | $230,575 | $814,355 | $354,250 | $4,164 | $1,948,344 |
| David Y. Liu, Ph.D. | 2020 | $441,300 | - | $352,429 | $266,987 | $11,133 | $1,071,849 |
| David Y. Liu, Ph.D. | 2019 | $428,450 | $120,300 | $424,881 | $218,509 | $7,458 | $1,199,598 |
| Suneel Gupta, Ph.D. | 2020 | $420,000 | - | $427,950 | $256,200 | $4,120 | $1,108,270 |
| Suneel Gupta, Ph.D. | 2019 | $377,467 | $60,150 | $693,789 | $196,767 | $3,564 | $1,331,737 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1377121/000110465921050202/tm212463-1_def14a.htm
What are Protagonist Therapeutics, Inc's Past Insider Trades?
Protagonist Therapeutics, Inc's most recent insider trade came on December 23, 2021 by Dinesh V. Patel Ph.D. who sold 15,000 units worth $482.17K . In the last 5 years, insiders at Protagonist Therapeutics, Inc have sold an estimated value of $8.03M and bought an estimated value of $37.28M worth of shares. Insider trading is most common in May, with the busiest year in 2018. The most active traders at the company are Dinesh V. Patel, Ph.D., President and CEO, David yLiu, Chief R&D Strategy Officer, and Harold E Selick, Director .
Protagonist Therapeutics, Inc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||